Noroviruses (NoVs) are estimated to be responsible for 60 to 80% of all human gastroenteritis outbreaks worldwide (4, 9, 16, 19, 23, 30, 34) . Norovirus infections have become an increasing problem in healthcare institutions such as nursing homes and hospitals because outbreaks often result in closed wards (6, 15, 19, 22) . Although the main mode of transmission in health institutions is person to person, NoVs are also efficiently transmitted via food, water, and contaminated surfaces (3, 17, 14, 21) . A low infectious dose, short-lived immunity, and high stability in the environment make these viruses especially contagious (5, 7) .
Noroviruses are classified into five genogroups (GI to GV), and human NoVs belong to genogroups GI, GII, and GIV (4, 17) . Since no unified genotyping system for NoVs exists, genogroups can be divided into various numbers of genotypes (1, 13, 33, 37) . The design of a single reverse transcriptase PCR (RT-PCR) assay for the detection of all genotypes has been a challenge due to the genomic diversity of NoVs (36) . Earlier RT-PCR assays were based on the polymerase region since this was expected to be the most conserved. In a recent study, however, the highest degree of conservation was demonstrated in the polymerase-capsid junction region (12) . Several broadly reactive real-time RT-PCR assays amplifying part of this junction have been developed (11, 12, 20, 26) . The sensitivity has varied between the assays; however, an evaluation of the different assays using a common panel of strains has not been performed. Reliable and rapid NoV diagnostics is important for correct interventions in different settings, e.g., in institutions and in food-borne outbreaks.
Due to the predominance of assays amplifying the polymerase region, NoV genotyping has been mainly based on the polymerase typing system in epidemiological studies. Most of these studies describe a predominant circulation of strains belonging to GII, especially in health institutions (4, 15, 25, 27, 29, 32, 35) . GII.4 has been the most common genotype in Europe during recent years, and two new genetic GII.4 variants have emerged since January 2002 (19, 22, 25) . Detailed genotype or sequence data are essential for the detection of new emerging variants and for the investigation of epidemiologically linked outbreaks.
The aims of the present study were to describe the molecular epidemiology of NoV strains circulating in Norway between 2000 and 2005, to compare four published NoV real-time RT-PCR assays on a panel of stool samples, and to use the best assay in the retesting of stool samples sent to the Norwegian Institute of Public Health between 1998 and 2004.
MATERIALS AND METHODS

Clinical specimens. (i) Molecular epidemiology. The Norwegian Institute of
Public Health is the national reference laboratory for NoVs. Stool samples from outbreak cases of gastroenteritis were included in the study. The samples were received between January 2000 and August 2005. The majority of the samples were from outbreaks in hospitals and nursing homes in different areas of Norway. An outbreak of gastroenteritis was defined as two or more cases of acute gastroenteritis occurring in a given setting within a period of 2 weeks. No screening data on other enteric agents were available for these samples.
(ii) RT-PCR comparison. Four real-time RT-PCR assays (10, 11, 20, 31) were compared by using a panel of 97 stool samples analyzed in our laboratory between 1998 and 2004. The panel included 76 NoV-positive and 11 NoVnegative samples as classified by a polymerase RT-PCR published by Vinje et al. (34, 36) . The remaining 10 samples had previously not been tested by the real-time RT-PCR. Based on the sequence data from the polymerase region of 42 NoV-positive samples, the following genotypes were included in the panel: GI.1, GI.2, GI.3, GI.4, GI.5, GII.1, GII.2, GII.3, GII.4, GII.6, GII.7, GIIb, and GIIc.
Retesting of stool samples. A total of 372 stool samples randomly collected from selected periods between November 1998 and April 2004 were subsequently retested by the real-time RT-PCR assay that performed best on the panel. A total of 56 (15%) of these samples had previously tested positive and 316 (85%) had tested negative with the in-house diagnostic RT-PCR assay used at the time (the nested RT-PCR or the conventional one-step RT-PCR).
Sample preparation and RNA extraction. Stool extracts (10%) were prepared in phosphate-buffered saline (pH 7.2 to 7.4) by standard methods immediately after arrival at the laboratory (8) . RNA was isolated from 140-l unfrozen stool extracts by QIAmp microspin columns (viral RNA minikit; QIAGEN) according to the manufacturer's protocol. The RNA was eluted in 60 l of elution buffer and aliquots were stored at Ϫ70°C until testing.
Diagnostic RT-PCRs. Three different diagnostic RT-PCR assays were used during the study period. An in-house nested RT-PCR was used between January 1996 and November 2003 (32), a conventional one-step RT-PCR assay was used between November 2003 and December 2004 (34) , and a real-time GI-GII duplex TaqMan assay has been used since January 2005 (11) . All kits were used for amplification according to manufacturer's protocol.
Real-time RT-PCRs included in the comparison. The primers and probes in the four published real-time RT-PCR assays (10, 11, 20, 31) are listed in Table 1 . Assays A, B, and C were based on the TaqMan technology, whereas assay D was based on the SYBR green technology. The QuantiTect probe RT-PCR kit (QIAGEN) and the QuantiTect SYBR green RT-PCR Kit (QIAGEN) were used for amplification.
Some of the published reaction and cycling conditions were slightly modified to optimize the reactions and to adapt the performance to our real-time PCR machine. Optimization was performed on four fecal samples containing different NoVs (two GI and two GII). Assay A included primers (250 nM), GI probe (250 nM), and GII probe (100 nM) under the following amplification conditions: (i) RT for 30 min at 50°C, (ii) 15 min at 95°C to activate the Taq polymerase, and (iii) 40 cycles of 15 s at 95°C and 60 s at 55°C. The same cycling conditions were used in all TaqMan assays, except for the annealing temperature that was increased to 56°C in assay B and to 60°C in assay C. Assay B included primers (600 nM), GI probe (400 nM), and GII probe (200 nM), while assay C used 200 nM concentrations of each of the primers and probe (GII). The SYBR green assay D included 500 nM concentrations of each primer, and the reverse transcription was run at 50°C for 30 min, followed by 15 min at 95°C and 40 cycles of 20 s at 95°C, 60 s at 50°C, and 6 s at 77°C (optical read). An optical read at 77°C was chosen because this was 2°C below the melting temperature of the specific amplicons, and detection of spurious products was eliminated. A melting-curve analysis completed the run in order to verify the specificity of the amplification products. Six PCR products with different melting points were also run in a gel to visualize the size of the amplicons. In all assays an increased ramp time was included between annealing and denaturation to optimize polymerization.
The real-time reactions were run on a SmartCycler (Cepheid) with a final reaction volume of 25 l. All samples yielding discordant results were retested. Samples that were negative in the duplex assays (A and D) were retested in a monoplex version of the same assays. A reduced concentration of the GI probe (100 nM) was used in the monoplex version of the assay A.
A negative control containing water and a positive RT-PCR control containing RNA from one GI-and one GII-positive stool sample were included in each run.
DNA sequencing and phylogenetic analysis. Genetic characterization was performed by direct sequencing of the PCR fragment. At least one positive sample per outbreak was processed for sequencing of the RNA polymerase region (240 nucleotides). PCR products were sequenced in both directions using the ABI Prism BigDye terminator cycle sequencing kit and the ABI Prism 310 genetic analyzer (Applied Biosystems). Sequences were edited by using Sequencher 3.0.1 software (Gene Codes Corp.). Multiple alignments and phylogenetic trees were constructed by using MEGA version 3.0 (18) .
The sequences obtained in the present study were aligned to the following EMBL/GenBank NoV genotype strains and to strains from the sequence database of European Network (14, 36) (Table 2) . Several other laboratories in Norway perform RT-PCR for NoVs, and the number of positive samples is routinely reported to our laboratory. These reports, however, do not allow us to determine whether the NoV-positive samples were from outbreaks or from sporadic cases. Figure 1 shows the monthly distribution of the NoV outbreaks diagnosed in our laboratory and the NoV-positive samples reported from all diagnostic laboratories. The positive samples diagnosed in our laboratory represent ca. 25% of all NoV-positive samples diagnosed in Norway. A clear increase was seen during winter and spring, with a peak between December and March. Between June and October, only a few NoV-positive outbreaks were observed. A total of 29 food-or waterborne (FW) outbreaks were detected during the study period, and all but one of these outbreaks were noninstitutional. The usual seasonality was not observed with the (Fig. 2) : four GI genotypes (GI.1, GI.3b, GI.4, and GI.6) and seven GII genotypes (GII.1, GIIc, GIIb, GII.2, GII.3, GII.4, and GII.7). Data for 10 GI outbreaks, the 25 sequenced FW outbreaks, the GII outbreaks not belonging to GII.4, and some of the panel (Fig. 2) .
Comparison of real-time RT-PCRs. Changes made to the reaction and cycling conditions yielded a higher analytical sensitivity (a lower cycle threshold [C T ] value)
. Assays A, B, and D detected the same four GI genotypes included in the panel, while none of the assays detected the GI.2 genotype ( Table 3) . The panel contained 12 GI-positive samples, and 9 were detected by assay A, 10 were detected by assay B, and 11 were detected by assay D. The average C T values for the nine GI samples detected by each assay were 25.7 for assay A, 30.7 for assay B, and 25.0 for assay D. The mean difference between C T values in the two TaqMan assays A and B was 4.9 Ϯ 2.6. The TaqMan assays A, B, and C showed identical results regarding the detection of the genotyped GII samples, whereas SYBR green assay D missed three of the samples. The average C T values for the 25 GII-positive samples detected by all of the assays were 23.8 for assay A, 22.2 for assay B, and 22.6 for assays C and D. The mean difference between C T values in the assays with highest and lowest average was 1.5 Ϯ 1.2, which indicates that the assays have similar analytical sensitivity for detecting GII strains included in the panel. The samples that tested negative in assays A and D were also negative in the monoplex versions of these two assays. The three TaqMan assays (A, B, and C) showed a high specificity regarding identification of correct NoV genogroup ( Table 3 ). The melting-curve analysis in the assay D showed melting points in the range of 79 to 83°C. However, it was not possible to differentiate between GI and GII strains based on melting point (data not shown). In NoV-containing samples the melting-curve analysis showed no interference from unspecific polymerization. Gel visualization of six PCR products obtained in assay D verified the amplicon size and the absence of spurious products. Regarding the remaining 55 untyped stool samples, similar results were obtained with assays A, B, and C, whereas several samples were not detected by assay D. According to assays A and B, 4 of the 55 samples contained GI strains. These four strains were also detected by assay D (Table 3) .
Based on the results from the conventional RT-PCR on 87 stool samples in the panel, 76 were NoV positive and 11 were NoV negative. Altogether, assay A detected 69 samples (13 GI and 56 GII), assay B detected 71 samples (14 GI and 57 GII), and assay D detected 61 samples. Assay C gave the highest score, with the detection of 58 GII-positive samples. The conventional RT-PCR detected the highest number of positive FIG. 2 . Phylogenetic tree derived from 12 NoV GI and 39 NoV GII strains detected in Norway during the study period. The phylogenetic tree was based on 240 bp from the polymerase region and was constructed by the neighbor-joining method using MEGA3 software. Branch lengths are related to the degree of divergence between the strains. The major branches are marked with GI and GII. Bootstrap values for branches of Ͼ50% are given. The food-or waterborne outbreaks are marked "FW," and the institutional outbreaks are marked "INSTITUTION." Data for GI outbreaks, FW outbreaks, GII outbreaks not belonging to GII.4, and some of the panel samples are presented. Two of the GI samples are only included in the stool panel. a A total of 87 samples had previously been tested by a conventional NoV RT-PCR and classified as NoV positive (n ϭ 76) or negative (n ϭ 11). Ten stool samples had not previously been tested. Genotyping of 42 strains was performed in the polymerase region. The table gives the number of samples with different GI and GII genotypes. All samples were tested by each of the assays.
b Assay A, duplex with TaqMan technology (11); assay B, monoplex (GI and GII) with TaqMan technology (10); assay C, monoplex (GII) with TaqMan technology (20) ; assay D, duplex with SYBR green technology (31) . 
DISCUSSION
The clear increase in NoV activity seen in many European countries during autumn 2002 was due to the emergence of a new GII.4 variant. A similar trend was seen in Norway, as indicated by the significant increase in the number of positive samples analyzed in or reported to our laboratory. Figure 1 shows the variation in NoV activity observed during the five seasons studied. In accordance with other studies, the highest This genotype has been shown to persist from year to year. A Ͻ5% nucleotide sequence difference was detected between the GII.4 sequences, and the different GII.4 variants clustered together in the phylogenetic tree (data not shown). Although the GII.4 genotype seems to undergo continuous genetic changes, only a few point mutations were seen in the polymerase region between the different GII.4 sequences. One of these mutations was detected in a specific motif, and the change in this motif reflected the GII.4 variant detected. However, to gain more insight into the pathogenic potential of the different variants, other regions, e.g., the capsid region, must be analyzed. The new GII. Table 2) .
The GIIb and GII.4 genotypes have been associated with the majority of hospital outbreaks (4, 25) , and this seems to be the case also in Norway. This was not surprising since the majority of outbreaks included in the present study were institutional. Due to the high hygienic level in hospitals, it has been speculated that only the most resistant NoV strains are capable of causing institutional outbreaks (25) . This may be one explanation for the global distribution of GII.4 strains in hospital outbreaks. However, little is known about the environmental stability, the dose needed to produce an active infection, or the pathogenic potential of different NoV genotypes. Different strains may also induce different degrees of immunity. To our knowledge, different virulence factors have not yet been linked to different genotypes. Figure 2 shows that the majority of the FW outbreaks were also caused by GII strains. This is probably due to the dominating circulation of NoV GII strains in the population. On the other hand, GI strains caused 8 of 25 FW outbreaks (32%) and 2 of 93 institutional outbreaks (2%), which indicates that GI strains may be more resistant to environmental conditions that favor FW transmission. This assumption is supported by a Finnish study in which the detection of GI strains in waterborne outbreaks was more frequent than expected (24) . However, due to the limited number of GI outbreaks detected in the present study, further investigation is needed.
The comparison of four published NoV real-time RT-PCRs showed that assay A satisfied the combined requirements for sensitivity and simplicity. Real-time RT-PCR is less cumbersome and safer with regard to cross-contamination than conventional RT-PCR. To optimize our NoV diagnostics, a published conventional polymerase RT-PCR was compared to a SYBR green assay (assay D) amplifying a different part of the polymerase region and to three TaqMan assays amplifying the polymerase-capsid junction (assays A, B, and C). Assay A, which detects the most prevalent genotypes, was included in the comparison for the convenience of running a GI and GII duplex reaction. Jothikumar et al. had previously demonstrated that assay A was more sensitive than the assay described by Kageyama et al. (11, 12) . These two assays contain identical GII reverse primer and probe. Loisy et al. also demonstrated that the GI assay described by Kageyama et al. performed poorly on NoV-positive shellfish (20) . Their modified version of the Kageyama GII primers and probe performed well and was therefore included in the present study (assay C). Assay B amplified a different part of the polymerase-capsid junction in GI strains compared to assay A, whereas the GII primers and probe were located in the same area as in assays A and C. SYBR green assay D had been shown to detect a broad spectrum of NoV genotypes (GI 1 to 5 and GII 1 to 8) and was included due to a different location in the polymerase region and the duplex form.
Conclusions regarding the specificity and sensitivity of the real-time assays included in the present study were based on the RT-PCR results on the panel (Table 3 ). This panel represents the different genotypes that circulated in Norway between 1998 and 2005. The panel was originally classified by the broadly reactive polymerase primers and the sequence of their amplicons (34) . These primers were improved variants of pub-lished primers which performed well in an international study on NoV RT-PCR assays (36) . The three TaqMan assays (A, B, and C) detected a similar number of NoV-positive samples. Although SYBR green assay D performed well on GI samples, the total number of positive samples detected was lower than with the TaqMan assays. These results are probably not due to a lower sensitivity of the SYBR green technology compared to the TaqMan technology. Some of the samples missed by the SYBR green assay D yielded low C T values in the TaqMan assays. This indicates a high NoV copy number, and these samples should therefore be NoV positive even in a less sensitive assay. The observed C T values for the assay D were also similar to the C T values in assays A, B, and C. The assay D primers were located in a different part of the genome, and this may have resulted in a lower detection rate of GII strains ( Table 3 ). The TaqMan assays showed equal NoV detection rates, and the main difference in performance between assays A and B is displayed in the C T values from the genotyped GI samples. The mean difference in the C T values was 4.9 Ϯ 2.5, with assay A yielding the best result. This indicates that assay A has a higher analytical sensitivity than assay B, but this may only partly explain why Jothikumar et al. failed to detect the GI samples with assay B in their comparison of assays A and B (11) . Regarding the clinical sensitivity, both assay A and assay B performed well in the present study. The lower analytical sensitivity observed in the detection of GI samples with assay B may be due to the location of primers and probes in a less conserved area of the polymerase-capsid junction (12) . The conventional RT-PCR detected the highest number of positive samples. This may be due to a bias in the panel because it was classified by the same conventional RT-PCR. In addition, the real-time PCRs were run on RNA that may have been degraded during storage. On the other hand, the real-time assays detected NoV in four stool samples previously classified as NoV negative.
Although assays A and B showed equal clinical sensitivity in the present study, assay A showed a higher analytical sensitivity for GI strains compared to assay B. Therefore, assay A probably has an increased clinical sensitivity on fecal samples with a low viral load. The practical and economical advantages of a duplex assay were also considered important when assay A was established as the new NoV-diagnostic RT-PCR. Although assay D is a duplex assay and SYBR green is a less expensive technology, the lower detection rate for GII samples and the lack of differentiation between GI and GII strains make it less suitable as a diagnostic tool. Assay C gave a slightly higher detection rate compared to the other assays and could be used as a first-line GII screening method.
Retesting of 372 randomly chosen stool samples previously analyzed in our laboratory between 1998 and 2004 was performed with assay A. The goal was to achieve an extended comparison of assay A and the conventional RT-PCRs and to reveal whether false negatives had contributed to the low prevalence of NoV-positive samples in Norway. The number of positive samples increased from 56 (15%) to 96 (26%). The results demonstrate the increased clinical sensitivity of assay A compared to the former diagnostic RT-PCRs. However, the difficulty of designing an RT-PCR assay that detects all NoV strains is demonstrated by our results since assay A did not detect all of the positive stool samples in our panel. It is, however, difficult to estimate the true false-negative rate of the RT-PCR methods used in the present study. Electron microscopy could probably have detected some samples missed by RT-PCR, i.e., new genetic variants, but was not available in our laboratory.
In summary, the NoV activity observed in Norway has been similar to that seen in other European countries during the same period. The present study also indicates that the strains circulating in Norway are similar to the strains detected in other countries. In general, DIVINE-NET has demonstrated the importance of common sequence databases in the detection of new NoV variants. It is also important to further enhance the capacity for national and international surveillance across Europe of NoV outbreaks.
